This interesting study applied a machine-learning algorithm and demonstrated an overall accuracy of 90.5% for predicting inhibitor development in children with #hemophilia A. ⁦JTH⁩ jthjournal.org/article/S1538-…

Excited to share 👇 “A major limitation of hemophilia A gene therapy is progressive loss of expression. Here the authors demonstrate that low-level expression of a gain-of-function factor VIII variant may safely restore normal hemostasis and permit durability of expression.”

Learn how to participate in Community Counts, a program led by ATHN and CDC, and get free yearly inhibitor testing at federally funded #Hemophilia treatment centers: bit.ly/3T2RvWb

Thank you JTH for publishing this important work by Dr. Maria T DeSancho and ATHN!

Visit cdc.gov/hemophilia-com… and get important data for your research project CDC_NCBDDD CDC

Today is the 1st day of #SickleCellAwarenessMonth So many awareness angles but let’s not forget that this is arguably the most neglected #GlobalHealth problem A baby with SCD is born every MINUTE Awareness is good but we need so much action. Who’s here for it?

This year's ATHN Data Summit is going to be epic! Don't miss it, register now: athn.org/events/data-su…

This year's ATHN Data Summit is going to be epic! Don't miss it, register now: athn.org/events/data-su…

#SickleCellAwarenessMonth D3 Let’s celebrate where we are now Children w/SCD born in this generation now have access to early diagnosis by newborn screening and begin hydroxyurea early in life (6-9 months) Kids now can and are living normal lives without restrictions!

A Proclamation on National Sickle Cell Awareness Month, 2024 whitehouse.gov/briefing-room/… via @whitehouse #SickleCellAwarenessMonth

athn.org/events/data-su…. .

🚨Break the cycle of neglect for #SickleCell disease.

We have dosed another #HA severe patient with AAV5 HA gene therapy#Roctavian, in #ABB #Haemophilia and Thrombosis centre in #Milan. Soon you will see the results

#sicklecellawareness #sicklecell ashpublications.org/ashclinicalnew…

ATHN is heading to #BDC to join our community in celebrating our work to improve lives for everyone who lives with a bleeding disorder. See you in Atlanta!

ATHN 12 hereditary antithrombin deficiency registry ▶️venous #thrombosis was THE clinical manifestation & frequently recurrent #DOACs were commonly prescribed & antithrombin was used in 35% of patients without adverse events. Dr. Maria T DeSancho Antonio Muñoz ATHN jthjournal.org/article/S1538-…

If you are interested to know how a wrong diagnosis could impact the management of a patient affected #with vWD and how to manage a surgery in VWD join us this afternoon. ERN EuroBloodNet EHC_Haemophilia

Yes, that's our member Melissa Creary, PhD, MPH of Michigan Public Health discussing access issues for gene therapy to cure #sicklecell disease on @npr: npr.org/sections/shots…

At least 40% of menstruating women and girls in Ontario are iron deficient. Dr. Michelle Michelle Sholzberg, hematologist at St. Michael's Hospital, spoke to CBC Podcasts' The Dose about what causes it and how to treat it. White Coat Black Art cbc.ca/listen/cbc-pod…

Make sure you're registered before registration closes! athn.org/events/data-su…